Jean Logan

Jean Logan

Auto-generated profile, based on publicly available information

Jean Logan

Department of Radiology, New York University Langone Medical Center, New York, NY 10016

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2006 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NVNora D Volkow
Nora D Volkow
GWGene-Jack Wang
Gene-Jack Wang
FTFrank Telang
Frank Telang
JFJoanna S. Fowler
Joanna S. Fowler
JLJean Logan
Jean Logan
CWChristopher Wong
Christopher Wong
The ability of drugs of abuse to increase dopamine in nucleus accumbens underlies their reinforcing effects. However, preclinical studies have shown that with repeated drug exposure neutral stimuli paired with the drug (conditioned stimuli) start to increase dopamine by themselves, which is an effect that could underlie drug-seeking behavior. Here we test whether dopamine increases occur to conditioned stimuli in human subjects addicted to cocaine and whether this is associated with drug craving. We tested eighteen cocaine-addicted subjects using positron emission tomography and [11C]raclopride (dopamine D2 receptor radioligand sensitive to competition with endogenous dopamine). We measured changes in dopamine by comparing the specific binding of [11C]raclopride when subjects watched a neutral video (nature scenes) versus when they watched a cocaine-cue video (scenes of subjects smoking cocaine). The specific binding of [11C]raclopride in dorsal (caudate and putamen) but not in ventral striatum (in which nucleus accumbens is located) was significantly reduced in the cocaine-cue condition and the magnitude of this reduction correlated with self-reports of craving. Moreover, subjects with the highest scores on measures of withdrawal symptoms and of addiction severity that have been shown to predict treatment outcomes, had the largest dopamine changes in dorsal striatum. This provides evidence that dopamine in the dorsal striatum (region implicated in habit learning and in action initiation) is involved with craving and is a fundamental component of addiction. Because craving is a key contributor to relapse, strategies aimed at inhibiting dopamine increases from conditioned responses are likely to be therapeutically beneficial in cocaine addiction.

9 September 2009 in JAMA
Verified
Journal Article
Open access
PDF file
NVNora D Volkow
Nora D Volkow
GWGene-Jack Wang
Gene-Jack Wang
SKScott H. Kollins
Scott H. Kollins
TWTim L. Wigal
Tim L. Wigal
JNJeffrey H. Newcorn
Jeffrey H. Newcorn
JSJames M. Swanson
James M. Swanson
Attention-deficit/hyperactivity disorder (ADHD) is characterized by symptoms of inattention, hyperactivity, or impulsivity that produce impairment across cognitive, behavioral, and interpersonal domains.1 Although for many years it was believed to be a disorder of childhood and adolescence, it is now recognized to also occur in adulthood. It is estimated that ADHD affects 3% to 5% of the US adult population,2 which makes it one of the most prevalent of all psychiatric disorders.

1 October 2008 in NeuroImage
Verified
Journal Article
Closed access
NVNora D Volkow
Nora D Volkow
GWGene-Jack Wang
Gene-Jack Wang
FTFrank Telang
Frank Telang
JFJoanna S. Fowler
Joanna S. Fowler
PTPanayotis K. Thanos
Panayotis K. Thanos
KPKith Pradhan
Kith Pradhan

18 March 2009 in JAMA
Verified
Journal Article
Open access
PDF file
NVNora D Volkow
Nora D Volkow
JFJoanna S. Fowler
Joanna S. Fowler
JLJean Logan
Jean Logan
DADavid Alexoff
David Alexoff
WZWei Zhu
Wei Zhu
KAKaren Apelskog-Torres
Karen Apelskog-Torres
Modafinil is a wake-promoting medication used in the treatment of narcolepsy and other sleep disorders. Modafinil may enhance cognition and is used off-label for the treatment of cognitive dysfunction in some psychiatric disorders (ie, schizophrenia, attention-deficit/hyperactivity disorder [ADHD]).1 Moreover, modafinil is increasingly being diverted for nonmedical use by healthy individuals with the expectation that it will improve cognitive performance.2 Although modafinil apparently has very low abuse liability (low reinforcing effects) in non–drug abusing individuals, the Physicians' Desk Reference cautions that it can produce psychoactive and euphoric effects typical of central nervous system stimulant drugs,3 and there is debate surrounding its potential for abuse.4,5

14 November 2007 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NVNora D Volkow
Nora D Volkow
GWGene-Jack Wang
Gene-Jack Wang
FTFrank Telang
Frank Telang
JFJoanna S. Fowler
Joanna S. Fowler
JLJean Logan
Jean Logan
CWChristopher Wong
Christopher Wong
The value of rewards (natural rewards and drugs) is associated with dopamine increases in the nucleus accumbens and varies as a function of context. The prefrontal cortex has been implicated in the context dependency of rewards and in the fixated high value that drugs have in addiction, although the mechanisms are not properly understood. Here we test the hypothesis that the prefrontal cortex regulates the value of rewards by modulating dopamine increases in nucleus accumbens and that this regulation is disrupted in addicted subjects. We used positron emission tomography to evaluate the activity of the prefrontal cortex (measuring brain glucose metabolism with [18F]fluorodeoxyglucose) and dopamine increases (measured with [11C]raclopride, a D2/D3receptor ligand with binding that is sensitive to endogenous dopamine) induced by the stimulant drug methylphenidate in 20 controls and 20 detoxified alcoholics, most of whom smoked. In all subjects, methylphenidate significantly increased dopamine in striatum. In ventral striatum (where the nucleus accumbens is located) and in putamen, dopamine increases were associated with the rewarding effects of methylphenidate (drug liking and high) and were profoundly attenuated in alcoholics (70 and 50% lower than controls, respectively). In controls, but not in alcoholics, metabolism in orbitofrontal cortex (region involved with salience attribution) was negatively associated with methylphenidate-induced dopamine increases in ventral striatum. These results are consistent with the hypothesis that the orbitofrontal cortex modulates the value of rewards by regulating the magnitude of dopamine increases in the ventral striatum and that disruption of this regulation may underlie the decreased sensitivity to rewards in addicted subjects.

5 August 2015 in The Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
HLHedok Lee
Hedok Lee
LXLulu Xie
Lulu Xie
MYMei Yu
Mei Yu
HKHongyi Kang
Hongyi Kang
TFTian Feng
Tian Feng
HBHelene Benveniste
Helene Benveniste
The glymphatic pathway expedites clearance of waste, including soluble amyloid β (Aβ) from the brain. Transport through this pathway is controlled by the brain9s arousal level because, during sleep or anesthesia, the brain9s interstitial space volume expands (compared with wakefulness), resulting in faster waste removal. Humans, as well as animals, exhibit different body postures during sleep, which may also affect waste removal. Therefore, not only the level of consciousness, but also body posture, might affect CSF–interstitial fluid (ISF) exchange efficiency. We used dynamic-contrast-enhanced MRI and kinetic modeling to quantify CSF-ISF exchange rates in anesthetized rodents9 brains in supine, prone, or lateral positions. To validate the MRI data and to assess specifically the influence of body posture on clearance of Aβ, we used fluorescence microscopy and radioactive tracers, respectively. The analysis showed that glymphatic transport was most efficient in the lateral position compared with the supine or prone positions. In the prone position, in which the rat9s head was in the most upright position (mimicking posture during the awake state), transport was characterized by “retention” of the tracer, slower clearance, and more CSF efflux along larger caliber cervical vessels. The optical imaging and radiotracer studies confirmed that glymphatic transport and Aβ clearance were superior in the lateral and supine positions. We propose that the most popular sleep posture (lateral) has evolved to optimize waste removal during sleep and that posture must be considered in diagnostic imaging procedures developed in the future to assess CSF-ISF transport in humans. SIGNIFICANCE STATEMENT The rodent brain removes waste better during sleep or anesthesia compared with the awake state. Animals exhibit different body posture during the awake and sleep states, which might affect the brain9s waste removal efficiency. We investigated the influence of body posture on brainwide transport of inert tracers of anesthetized rodents. The major finding of our study was that waste, including Aβ, removal was most efficient in the lateral position (compared with the prone position), which mimics the natural resting/sleeping position of rodents. Although our finding awaits testing in humans, we speculate that the lateral position during sleep has advantage with regard to the removal of waste products including Aβ, because clinical studies have shown that sleep drives Aβ clearance from the brain.